Meiji Yasuda Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $433K | Sell |
10,154
-52,998
| -84% | -$2.88M | 0.02% | 388 |
|
|
2026
Q1 | $3.96M | Sell |
63,152
-3,129
| -5% | -$250K | 0.2% | 140 |
|
|
2025
Q4 | $6.32M | Sell |
66,281
-5,043
| -7% | -$494K | 0.3% | 101 |
|
|
2025
Q3 | $6.96M | Sell |
71,324
-1,084
| -1% | -$112K | 0.33% | 88 |
|
|
2025
Q2 | $7.78M | Sell |
72,408
-20,242
| -22% | -$2.05M | 0.39% | 69 |
|
|
2025
Q1 | $9.35M | Sell |
92,650
-3,905
| -4% | -$393K | 0.38% | 67 |
|
|
2024
Q4 | $8.62M | Buy |
96,555
+16,184
| +20% | +$1.42M | 0.33% | 78 |
|
|
2024
Q3 | $6.74M | Buy |
80,371
+48,225
| +150% | +$3.8M | 0.26% | 101 |
|
|
2024
Q2 | $2.48M | Buy |
32,146
+6,120
| +24% | +$448K | 0.1% | 195 |
|
|
2024
Q1 | $1.78M | Buy |
26,026
+8,315
| +47% | +$535K | 0.08% | 235 |
|
|
2023
Q4 | $1.02M | Sell |
17,711
-445
| -2% | -$23.8K | 0.05% | 319 |
|
|
2023
Q3 | $959K | Buy |
18,156
+3,100
| +21% | +$163K | 0.04% | 326 |
|
|
2023
Q2 | $814K | Buy |
15,056
+695
| +5% | +$36.3K | 0.04% | 317 |
|
|
2023
Q1 | $718K | Sell |
14,361
-30
| -0.2% | -$1.41K | 0.04% | 336 |
|
|
2022
Q4 | $666 | Sell |
14,391
-1,618
| -10% | -$70.1K | 0.03% | 382 |
|
|
2022
Q3 | $620K | Sell |
16,009
-2,460
| -13% | -$98.7K | 0.04% | 382 |
|
|
2022
Q2 | $688K | Buy |
18,469
+1,590
| +9% | +$64.7K | 0.04% | 387 |
|
|
2022
Q1 | $748K | Sell |
16,879
-1,645
| -9% | -$71.3K | 0.04% | 378 |
|
|
2021
Q4 | $787K | Buy |
18,524
+1,748
| +10% | +$73.5K | 0.05% | 307 |
|
|
2021
Q3 | $728K | Sell |
16,776
-810
| -5% | -$35.8K | 0.05% | 306 |
|
|
2021
Q2 | $752K | Buy |
17,586
+1,160
| +7% | +$48.8K | 0.04% | 307 |
|
|
2021
Q1 | $635K | Buy |
16,426
+6,645
| +68% | +$252K | 0.05% | 305 |
|
|
2020
Q4 | $352K | Sell |
9,781
-540
| -5% | -$19.5K | 0.03% | 312 |
|
|
2020
Q3 | $394K | Sell |
10,321
-10,770
| -51% | -$415K | 0.04% | 275 |
|
|
2020
Q2 | $741K | Buy |
21,091
+10,350
| +96% | +$373K | 0.07% | 244 |
|
|
2020
Q1 | $350K | Sell |
10,741
-13,380
| -55% | -$523K | 0.07% | 213 |
|
|
2019
Q4 | $1.09M | Sell |
24,121
-8,920
| -27% | -$373K | 0.09% | 234 |
|
|
2019
Q3 | $1.34M | Sell |
33,041
-410
| -1% | -$17.4K | 0.11% | 204 |
|
|
2019
Q2 | $1.44M | Sell |
33,451
-16,310
| -33% | -$627K | 0.12% | 191 |
|
|
2019
Q1 | $1.91M | Sell |
49,761
-5,090
| -9% | -$194K | 0.16% | 154 |
|
|
2018
Q4 | $1.94M | Sell |
54,851
-860
| -2% | -$31.2K | 0.18% | 148 |
|
|
2018
Q3 | $2.15M | Buy |
55,711
+1,320
| +2% | +$46.1K | 0.17% | 151 |
|
|
2018
Q2 | $1.78M | Sell |
54,391
-1,180
| -2% | -$35.6K | 0.16% | 154 |
|
|
2018
Q1 | $1.52M | Buy |
55,571
+3,360
| +6% | +$91.3K | 0.14% | 176 |
|
|
2017
Q4 | $1.29M | Hold |
52,211
| – | – | 0.12% | 207 |
|
|
2017
Q3 | $1.52M | Hold |
52,211
| – | – | 0.15% | 174 |
|
|
2017
Q2 | $1.45M | Sell |
52,211
-9,800
| -16% | -$260K | 0.15% | 177 |
|
|
2017
Q1 | $1.54M | Buy |
62,011
+10,730
| +21% | +$261K | 0.16% | 155 |
|
|
2016
Q4 | $1.11M | Buy |
51,281
+33,770
| +193% | +$737K | 0.12% | 197 |
|
|
2016
Q3 | $417K | Buy |
17,511
+4,720
| +37% | +$113K | 0.05% | 346 |
|
|
2016
Q2 | $299K | Buy |
+12,791
| New | +$277K | 0.04% | 367 |
|
Other funds holding BSX
Meiji Yasuda Asset Management's BSX Position: Q2 2026 in Review
Meiji Yasuda Asset Management reduced its Boston Scientific (BSX) stake by 84% in Q2 2026, selling an estimated $2.88M and leaving 10,154 shares worth $433K. The position accounts for 0.02% of the portfolio, ranked #388.
Meiji Yasuda Asset Management first reported a position in BSX in Q2 2016 and has held it in 41 quarters since. The position peaked at $9.35M in Q1 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Meiji Yasuda Asset Management held 10,154 shares of Boston Scientific worth $433K as of Q2 2026.
- Meiji Yasuda Asset Management sold 52,998 Boston Scientific shares in Q2 2026, an estimated $2.88M.
- Boston Scientific made up 0.02% of Meiji Yasuda Asset Management's portfolio in Q2 2026, its #388 holding.
- Meiji Yasuda Asset Management first reported a position in Boston Scientific in Q2 2016 and has held it in 41 quarters since.
- Meiji Yasuda Asset Management's Boston Scientific position peaked at $9.35M in Q1 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Meiji Yasuda Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.